The startup develops AI medical diagnosis software that utilizes endoscopic data to detect cancer and precancerous conditions in real-time. This technology enables proactive disease management by identifying risks early, allowing patients to engage in preventive care before cancer develops.
Funding
Funding not disclosed
Founders
Product
Problem
Endoscopic procedures rely on visual inspection, which can miss subtle precancerous lesions, leading to delayed diagnosis and treatment of conditions like stomach cancer. The subjective nature of visual assessment can also result in variability in diagnostic accuracy among different endoscopists.
Solution
The startup provides an AI-powered diagnostic platform that analyzes endoscopic video feeds in real-time to detect and characterize potentially cancerous or precancerous tissues. By applying advanced image recognition and deep learning algorithms, the system enhances the endoscopist's ability to identify subtle anomalies that may be missed by the human eye. The platform aims to improve the accuracy and consistency of early cancer detection, enabling proactive disease management and timely intervention. The technology empowers effective prognosis management and stomach cancer prevention through real-time identification of pre-cancerous risks during gastroscopy.
Target Audience
The primary target audience includes gastroenterologists, hospitals, and clinics performing endoscopic procedures, particularly those focused on early cancer detection and prevention.
Features
- Real-time analysis of endoscopic video streams
- AI-driven detection and characterization of suspicious lesions
- Integration with existing endoscopic equipment
- Cloud-based platform for data storage and analysis
- Algorithms trained on a large dataset of endoscopic images